PeterLeWittMD
Neurology • West Bloomfield, MIMovement Disorder, Neurodegenerative, Dementia & Geriatrics
Physician
Dr. LeWitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6777 W Maple Rd
West Bloomfield, MI 48322Phone+1 248-325-2452Fax+1 248-325-3115
Education & Training
National Institutes of HealthFellowship, 1980 - 1983
Stanford Health Care1977 - 1980
Brown UniversityM.Med.Sc., Biochemical Pharmacology, 1971 - 1975
The Warren Alpert Medical School of Brown UniversityClass of 1975
Certifications & Licensure
MI State Medical License 1983 - 2027
MD State Medical License 1982 - 1984
PA State Medical License 1976 - 1978- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease Start of enrollment: 2007 Oct 01
- Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease Start of enrollment: 2012 Apr 01
- Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT) Start of enrollment: 2012 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 100 citationsSignificant Linkage of Parkinson Disease to Chromosome 2q36-37Nathan Pankratz, William C. Nichols, Sean K. Uniacke, Cheryl Halter, Alice Rudolph
American Journal of Human Genetics. 2003-04-01 - 167 citationsHeterozygosity for a mutation in the parkin gene leads to later onset Parkinson diseaseTatiana Foroud, Sean K. Uniacke, L. Liu, Nathan Pankratz, Anja Rudolph
Neurology. 2003-03-11 - 99 citationsPreclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.Danna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, Jennifer C Sasaki, René Meisner
Science Translational Medicine. 2022-06-08
Press Mentions
Phase 1 Trial Set to Test First Live Biotherapeutics in Parkinson’sFebruary 23rd, 2022- 4D Pharma Announces FDA Clearance of IND Application for Live Biotherapeutics MRx0005 and MRx0029 for the Treatment of Parkinson’s DiseaseFebruary 22nd, 2022
- HIMSS21 Day 3 Roundup: Sharecare Acquires CareLinx, Verizon Telehealth, SamsungAugust 11th, 2021
- Join now to see all
Professional Memberships
- Movement Disorder SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
